株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

流行性耳下腺炎(おたふく風邪):世界の治験動向

Mumps Global Clinical Trials Review, H2, 2015

発行 GlobalData 商品コード 350886
出版日 ページ情報 英文 76 Pages
即納可能
価格
本日の銀行送金レート: 1USD=115.27円で換算しております。

2016年12月31日まで 年末キャンペーン割引: GlobalData社発行レポート
ご注意: ショッピングカートでは適用されませんので、割引価格についてはお問い合わせください

Back to Top
流行性耳下腺炎(おたふく風邪):世界の治験動向 Mumps Global Clinical Trials Review, H2, 2015
出版日: 2015年12月30日 ページ情報: 英文 76 Pages
概要

当レポートでは、流行性耳下腺炎(おたふく風邪)に関する臨床研究の最新動向について分析し、疾患・治療法の概要や、G7およびE7諸国における治験の状況、地域・フェーズ(相)・段階別の進行状況、有望なスポンサー、各企業・研究機関での研究の進行状況、有望な薬剤の比較といった情報を盛り込んでお届けします。

当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • 上位5ヶ国における治験件数; アジア太平洋地域
    • 上位5ヶ国における治験件数; 欧州
    • 主要国における治験件数; 北米
    • 主要国における治験件数; 中東/アフリカ地域
    • 主要国における治験件数; 中南米

G7諸国における治験件数:流行性耳下腺炎(おたふく風邪)治験件数の感染症治験件数に対する比率

フェーズ(相)別治験件数: G7諸国

G7諸国における治験件数:フェーズ(相)別

E7諸国における治験件数:流行性耳下腺炎(おたふく風邪)治験件数の感染症治験件数に対する比率

フェーズ(相)別治験件数: E7諸国

E7諸国における治験件数:フェーズ(相)別

フェーズ(相)別治験件数

  • フェーズ(相)別の進行中治験件数

進捗状況別の治験件数

評価項目別の治験件数

一定期間に採用された被験者数

スポンサーの種類別の治験件数

有望なスポンサー

治験主要参加企業 - 流行性耳下腺炎(おたふく風邪)治療薬

有望な薬剤

治験プロファイルの基本情報

付録

図表

目次
Product Code: GDHC3158CTIDB

GlobalData's clinical trial report, "Mumps Global Clinical Trials Review, H2, 2015" provides an overview of Mumps clinical trials scenario. This report provides top line data relating to the clinical trials on Mumps. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Mumps to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Mumps to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Mumps Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profile Snapshots
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Mumps Therapeutics, Global, Clinical Trials by Region, 2015*
  • Mumps Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Mumps Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Mumps Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015*
  • Mumps Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Mumps Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Mumps Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015*
  • Mumps Therapeutics Clinical Trials, Central and South America, Top Countries, 2015*
  • Proportion of Mumps to Infectious Disease Clinical Trials, G7 Countries (%), 2015*
  • Mumps Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Mumps Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Mumps to Infectious Disease Clinical Trials, E7 Countries (%), 2015*
  • Mumps Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Mumps Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Mumps Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Mumps Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Mumps Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Mumps Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Mumps Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Mumps Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Mumps Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Mumps Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Mumps Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*

List of Figures

  • Mumps Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Mumps Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Mumps Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Mumps Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015*
  • Mumps Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Mumps Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Mumps Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015*
  • Mumps Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015*
  • Proportion of Mumps to Infectious Disease Clinical Trials, G7 Countries (%), 2015*
  • Mumps Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Mumps Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Mumps to Infectious Disease Clinical Trials, E7 Countries (%), 2015*
  • Mumps Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Mumps Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Mumps Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Mumps Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Mumps Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Mumps Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Mumps Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Mumps Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Mumps Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Mumps Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Mumps Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top